We describe the management of a parturient with severe primary pulmonary hypertension who underwent caesarean section. A multi-disciplinary approach was used. She was admitted to the intensive care unit perioperatively for invasive monitoring and trial of inhaled nitric oxide. Anaesthesia was provided by combined spinal-epidural block.
Primary pulmonary hypertension (PPH) is a rare disease of unknown aetiology, characterized by raised pulmonary artery pressure, which results in progressive right heart failure and eventual death. It is most commonly seen in women of child-bearing age and the median survival from onset of symptoms is 2.8 years 1 . The haemodynamic stresses of pregnancy, particularly during the post-partum period, are poorly tolerated. The maternal mortality rate is reported to be as high as 50% 2 . Patients with PPH are therefore generally advised against pregnancy. However, in the majority of cases associated with pregnancy, the diagnosis is first made during the pregnancy 3 .
We report the case of a pregnant woman with PPH who failed to respond to inhaled nitric oxide (NO), but who underwent successful anaesthesia for caesarean section using a combined spinal-epidural technique.
CASE HISTORY
A 30-year-old woman with pulmonary hypertension (pulmonary artery pressure (PAP) 85/55) and worsening right heart failure was admitted from a referral hospital for management of delivery.
She was at 34 weeks gestation in her second pregnancy. Her first pregnancy 15 years earlier had been uncomplicated. The patient had a history of intravenous drug abuse and had been on a methadone program for two years. She was previously prescribed dexamphetamine for attention deficit disorder, continued to smoke 20 cigarettes per day, and was hepatitis C positive with normal liver function tests.
She had initially presented at 22 weeks gestation with worsening dyspnoea (New York Heart Association (NYHA) grade III). An echocardiogram (ECHO) showed pulmonary hypertension, with pulmonary systolic pressures of 60 mmHg. The history of shortness of breath predated pregnancy. She also complained of being easily fatigued and of episodes of syncope. An ECHO two years previously was reported as normal.
The patient had been noncompliant with hospital appointments and did not re-present until 28 weeks gestation. At that time she had massive ascites, bilateral lower limb oedema and raised jugular venous pressure to the angle of the jaw. An ECHO showed marked deterioration in pulmonary hypertension, right ventricular dilatation and tricuspid incompetence. She was admitted to hospital and treated with diuretics, fluid restriction and was anticoagulated with enoxaparin.
Clinically, her condition improved and another ECHO at 32 weeks showed moderate improvement of the pulmonary hypertension. Investigations indi-cated a likely diagnosis of primary pulmonary hypertension.
At this stage a plan was made to perform an elective caesarean section at 34 weeks gestation. However, an ECHO at 34 weeks gestation showed further increases in pulmonary artery pressures and further right ventricular dilatation. She was transferred to our tertiary referral centre for subsequent management.
A multidisciplinary team comprising cardiology, anaesthetic and critical care specialities was organized by the obstetric team and a decision was made to deliver the baby by caesarean section. Corticosteroids were administered to accelerate fetal lung development in anticipation of early delivery. The last dose of enoxaparin was given 24 hours preoperatively.
Preoperative examination was consistent with severe pulmonary hypertension and right ventricular failure. ECHO showed a right ventricular end-diastolic diameter of 50 mm (normal <30 mm), with severe tricuspid regurgitation and a systolic pulmonary artery pressure of 72 mmHg, which was 60% of systemic arterial pressure. On room air, the pulse oximeter showed oxygen saturation of 94%.
On the day prior to surgery she was electively transferred to the intensive care unit, where an arterial line and pulmonary artery catheter (PAC) capable of measuring cardiac output (CO) and mixed venous oxygen saturations continuously (CCO/SvO 2 ) were inserted. Insertion of the PAC was uncomplicated, but difficult because of orthopnoea. Initial readings acquired were a PAP of 85/55, CO 6.8 l/min (normal 6.2±1 l/min during pregnancy), central venous pressure (CVP) 26 mmHg and arterial blood pressure (ABP) 105/50 mmHg.
Nasal oxygen 2 l/min was applied and the PAP fell to 60 mmHg, but no change in pulmonary haemodynamics occurred with administration of NO in concentrations of 10-40 ppm. The patient would only accept application of the NO by nasal prongs.
On the morning of surgery she was transferred to the operating theatre. In the anaesthetic room monitoring of PAP, ABP, ECG and pulse oximetry were continued. She received 2 litres of oxygen and 1 litre NO (estimated 40 ppm) per minute.
A combined spinal epidural technique using an 18 gauge Tuohy needle was performed at lumbar 3/4 intervertebral space in the sitting position. Fentanyl 20 µg and morphine 150 µg were administered via the spinal needle. No local anaesthetic was given intrathecally. The epidural catheter was then placed. After ascertaining the absence of an intravenous or subarachnoid effect after a 3 ml test dose of 2% lignocaine with 1:200,000 adrenaline, a further 12 ml of solution was carefully titrated via the epidural catheter in incremental doses of 3 ml over a 15 minute period. The ABP fell gradually from 135/65 to 110/60 during this time but the PAP remained stable. Epidural anaesthesia was confirmed with loss of sensation to ice at the fifth thoracic dermatome on the right and sixth thoracic dermatome on the left.
In the operating room the patient was positioned supine with left uterine displacement and this was tolerated. Her condition remained stable during the surgical procedure and there was little change in monitored variables except post-delivery of a healthy infant, when 5 IU oxytocin was administered by slow infusion via the burette. A fall in ABP to 100/60 mm Hg and a rise in PAP from 70/35 to 80/40 were seen. No further oxytocin was given.
Intraoperative blood loss was less than 500 ml and the total intravenous crystalloid replacement was 600 ml. No inotropes or vasodilators were required.
The patient was transferred back to the intensive care unit postoperatively where the NO was slowly weaned over 24 hours. The epidural catheter was removed on return to ICU to allow anticoagulation with intravenous infusion of sodium heparin six hours postoperatively.
Regular paracetamol and diclofenac were prescribed and a morphine patient controlled analgesia (PCA) device was commenced six hours after surgery. The daily methadone dose was given. An early review by the drug and alcohol and acute pain teams was organized.
On the first postoperative day a dobutamine infusion was commenced to optimise myocardial function. The response to dobutamine was a rise in CO from 3.4 to 5.0 l/min with minimal change in systemic vascular resistance (SVR) and PAP. Fluid restriction to 1.5 l per day and frusemide were continued, as was dobutamine for four days, after which low dose captopril was commenced.
The patient remained in intensive care for two postoperative days and was then monitored for five days in the coronary care unit, when the PAC and arterial cannula were removed.
Her postoperative course was complicated by raised transaminases (aspartate aminotransferase (AST) 1203 and alanine aminotransferase (ALT) 591). An ultrasound of her liver and biliary tree indicated mild dilatation of the hepatic veins and inferior vena cava, consistent with right heart failure. The transaminase levels gradually fell and the ALT was 103 at patient discharge three weeks later.
DISCUSSION
Pulmonary hypertension is defined as a mean pulmonary artery pressure greater than 25 mmHg at rest or 30 mmHg during exercise 4, 5 . A diagnosis of primary pulmonary hypertension is made when leftsided valvular heart disease, myocardial disease, congenital heart disease, or any respiratory, connective tissue and chronic thromboembolic disease have been excluded 5 .
The aetiology of PPH is unknown, but an interaction between an environmental triggering stimulus and genetic susceptibility may be involved 4 . Potential triggers include anorexic agents 6 , amphetamines 5 and crack cocaine inhalation 4 .
The increased pulmonary vascular resistance in PPH occurs because of vasoconstriction, arterial remodelling and in-situ thrombosis 5 . Medial wall hypertrophy is the earliest pathological feature, while intimal proliferation and fibrosis occurs later 5 .
There is no known cure for PPH. Current medical and surgical treatments involve anticoagulation, vasodilators and transplantation. Both pulmonary and deep venous thrombosis are complications of PPH. Two uncontrolled studies suggest increased survival in patients treated with anticoagulants 4,5 .
Vasodilators including prostacyclin, nitric oxide, adenosine and calcium channel blockers have been used in PPH. The aim of vasodilator therapy is to reduce pulmonary artery pressure and increase cardiac output, without systemic hypotension.
Intravenous nitrovasodilators and prostacyclin (epoprostenol) are non-selective pulmonary vasodilators. However neither is selective for the pulmonary circulation, and they may induce systemic vasodilation with hypotension, which will impair right ventricular perfusion. Epoprostenol also inhibits platelet aggregation and vascular intimal proliferation in PPH 4, 5 . Continuous epoprostenol infusion improves symptoms, haemodynamic parameters and survival in severe PPH 4 . Inhalation of the synthetic prostacyclin analogue iloprost causes a selective fall in pulmonary artery pressure, but the duration of effect is limited to 30 to 90 minutes 7 . Concerns about the peripartum use of prostacyclin include effects on uterine blood flow 8 , uterine relaxation and the potential for haemorrhage 9, 10 . Administration of prostacyclin during pregnancy may increase the risk of fetal abnormalities 9, 10 .
The most specific agent for the pulmonary circulation is inhaled nitric oxide (NO) 5 . Other authors have described the successful use of NO in decreasing PAP in PPH 11 and in the perioperative management of pregnant patients undergoing caesarean section 8, [12] [13] [14] .
The pulmonary vasodilator response to intravenous epoprostenol and adenosine are usually the same as that of NO, and iloprost produces selective effects similar to those of NO 5 .
The use of vasodilators is not universally successful or predictable in PPH 5 . Fewer than 30% of patients respond to NO, adenosine or prostacyclin during acute vasoreactivity testing 4 . Long-term vasodilator treatment with calcium channel blockers is indicated only in this subset of patients 4 .
Pathological studies indicate that there is a correlation between the haemodynamic response to vasodilators and the ratio of vessel intima to total pulmonary vascular cross sectional area 15 . The more marked the intimal area the less response to vasodilators -that is, the vessel becomes "fixed" functionally 15 .
We suggest that elective preoperative PAC insertion and trial with selective pulmonary vasodilators such as NO is worthwhile in patients with this condition. Rebound pulmonary hypertension is a potentially dangerous effect of inhaled NO therapy withdrawal 16, 17 , therefore we elected to wean the NO slowly after delivery.
Inhalation of NO by nasal prongs has previously been described in a pregnant patient with PPH 14 .
Obvious problems with this method of administration include difficulty in scavenging and in measurement of nitrogen dioxide levels.
The literature on management of the non-pregnant patient with PPH is extensive, whilst information on pregnant patients is mainly limited to case reports that are too few in number to make conclusive recommendations. Maternal outcome in PPH is better with early diagnosis, early hospital admission, and individually tailored management during pregnancy 3 . Care focused on the post-delivery phase is recommended as most patients die in the early postpartum period due to right heart failure 3, 18 . Caesarean section, the severity of the pulmonary hypertension, and number of previous pregnancies are risk factors for maternal death 3 . The type of anaesthesia 3 and the peri-partum use of the PAC 3, 19 do not appear to influence outcome.
The literature reports a mortality rate of 37% for vaginal delivery and approaching 63% for caesarean section 3 . A multidisciplinary decision was made to deliver our patient by caesarean section as it was considered that she would not tolerate the physiological stresses of vaginal delivery because of her worsening right ventricular failure. At 34 weeks gestation the risk of an unsuccessful induction was also high because of cervical immaturity. Induction of labour with prostaglandin F2α and oxytocin can lead to pulmonary vasoconstriction 8 .
The anaesthetic management of caesarean section in the patient with PPH and right ventricular compromise presents a challenge. Both regional and general anaesthesia have been described 8, [19] [20] [21] [22] . In general hypoxia, hypercarbia, acidosis, anxiety and pain should be avoided because these exacerbate pulmonary hypertension.
Neuraxial block may cause a precipitous drop in systemic vascular resistance and venous return leading to a fall in cardiac output, hypotension, right ventricular ischaemia and cardiovascular collapse. Epidural anaesthesia is considered a safe option if it is conducted carefully and slowly, using invasive monitoring.
We employed a combined spinal-epidural technique, using both intrathecal morphine and fentanyl, and then epidural local anaesthetic. We believe that this is the first description of this technique in a patient with PPH undergoing caesarean section. The intrathecal administration of fentanyl and morphine was chosen because of our extensive experience with this approach in our institution. Spinal fentanyl enhances the quality of regional anaesthesia, while morphine provides excellent analgesia that rarely requires parenteral opioid supplementation postoperatively. Our patient however received her usual methadone and a PCA on the first postoperative day because of a history of opioid dependence. The dose of intrathecal morphine we used does not cause respiratory depression in obstetric patients 23, 24 . The epidural catheter was removed immediately postoperatively to allow reinstitution of anticoagulation. The shorter half-life of standard heparin made it preferable to a low molecular weight heparin in the early postoperative period, because of the risk of haemorrhage.
The use of a PAC is controversial in PPH 3, 18, 19 . There is an increased risk of thrombosis and pulmonary artery rupture in PPH 25 . A fall in SVR can be detrimental in the patient with PPH. Use of direct arterial blood pressure monitoring and continuous cardiac output monitoring via the PAC is of benefit in the rapid detection of a reduction in cardiac output and systemic blood pressure.
Oxytocin may cause an acute rise in PVR, systemic vasodilatation, and a fall in systemic blood pressure and cardiac output 19 , so must be used with extreme caution in this patient group. Others report no problems with oxytocin 12, 21 .
The time of greatest risk of cardiovascular collapse and death is in the early post-partum period. It is postulated that this is due to a sudden increase in venous return, with acute right ventricular dilatation and failure, a fall in cardiac output and then left ventricular ischaemia, failure and arrhythmias 18 . We therefore continued haemodynamic monitoring in the intensive care unit for 48 hours following delivery, followed by ongoing monitoring in the coronary care unit for eight days. The postoperative course was complicated by right ventricular failure requiring dobutamine and later captopril.
The rise in hepatic transaminases was attributed to the presence of hepatic congestion and was expected because of her positive serology for hepatitis C. The natural history of hepatitis C during pregnancy is an exacerbation of disease post partum 26 .
In summary we describe the successful outcome of a patient with severe PPH who underwent caesarean section. The factors that contributed to this result included the involvement of a multidisciplinary care team, a carefully titrated and closely monitored anaesthetic and extended perioperative cardiopulmonary monitoring.
